ALEXANDRA MCCARTHY

Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant|Medical BELLEVUE, OH NPI 1245748656

General Payments — all program years on this page

$1,280.19

  • Category: General Payments
  • Program years: PY2021–2022
  • Record count: 25
  • As of (CMS publication): 2026-01-23

Latest program year (PY2022): $900.93 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2022) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $800.9420
Education $99.991

By paying entity

Latest program year (PY2022) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $379.264
2022 $900.9321

Records — PY2022 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
918388701 Lilly USA, LLC $18.12 08/02/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
923889747 Biohaven Pharmaceutical Holding Company Ltd. $15.61 01/28/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
932666345 E.R. Squibb & Sons, L.L.C. $122.64 06/23/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
932666349 E.R. Squibb & Sons, L.L.C. $122.91 02/23/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
939099821 GENZYME CORPORATION $18.36 01/05/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
939099833 GENZYME CORPORATION $22.00 02/15/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
939099843 GENZYME CORPORATION $21.38 03/23/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
939099851 GENZYME CORPORATION $23.23 04/27/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
939099855 GENZYME CORPORATION $91.57 04/04/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
939099873 GENZYME CORPORATION $22.65 06/06/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
939099875 GENZYME CORPORATION $99.99 07/18/2022 Education Undisputed 01/23/2026 View at CMS
939100041 GENZYME CORPORATION $20.50 08/24/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
939703825 Amgen Inc. $19.75 11/08/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
939703829 Amgen Inc. $119.96 09/08/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
954412873 Teva Pharmaceuticals USA, Inc. $2.63 08/03/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
954412947 Teva Pharmaceuticals USA, Inc. $120.88 03/09/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
954412949 Teva Pharmaceuticals USA, Inc. $1.25 08/24/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
954412979 Teva Pharmaceuticals USA, Inc. $21.64 02/22/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
954412981 Teva Pharmaceuticals USA, Inc. $5.42 08/24/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
954413015 Teva Pharmaceuticals USA, Inc. $5.67 09/26/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
954413029 Teva Pharmaceuticals USA, Inc. $4.77 09/27/2022 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.